Concepedia

R.J. Hohl

RH

9

Publications

699

Citations

9

H-Index

2001

Active since

Affiliations

University of Iowa(Current)

Cancer Institute (WIA)

Pennsylvania State University

R.J. Hohl is an author at University of Iowa specializing in medicine, pharmacology, and cell transplantation.

Top concepts

Publications per year

2001–2017

9

Publications

9

O2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate

Joshua D. Schoenfeld, Zita A. Sibenaller, Kranti A. Mapuskar et al. · Cancer Cell · 2017 · 427 citations · Full text

Changes in Erythropoietin Pharmacokinetics following Busulfan-Induced Bone Marrow Ablation in Sheep: Evidence for Bone Marrow as a Major Erythropoietin Elimination Pathway

Sunny Chapel, P. Veng‐Pedersen, R.J. Hohl et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 69 citations

Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207

Jonathan E. Rosenberg, Susan Halabi, Ben L. Sanford et al. · Annals of Oncology · 2008 · 53 citations · Full text

, , +6

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas

Thomas E. Witzig, Hui Tang, Ivana N. Micallef et al. · Blood · 2011 · 43 citations · Full text

Pharmacokinetic tracer kinetics analysis of changes in erythropoietin receptor population in phlebotomy‐induced anemia and bone marrow ablation

P. Veng‐Pedersen, Sunny Chapel, Nidal Al‐Huniti et al. · Biopharmaceutics & Drug Disposition · 2004 · 28 citations

Rows per page

1–5 of 9